
    
      The study was terminated on Oct. 18, 2007. This study is not a post approval commitment
      study. Pfizer decided to cancel new trials because of the decision to withdraw ExuberaÂ®
      (inhaled insulin) due to lack of market performance and not for safety reasons.
    
  